Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report

Serpil Erzurum, Sharon I. Rounds, Troy Stevens, Micheala Aldred, Jason Aliotta, Stephen L. Archer, Kewal Asosingh, Robert Balaban, Natalie Bauer, Jahar Bhattacharya, Harm Bogaard, Gaurav Choudhary, Gerald W. Dorn, Raed Dweik, Karen Fagan, Michael Fallon, Toren Finkel, Mark Geraci, Mark T. Gladwin, Paul M. HassounMarc Humbert, Naftali Kaminski, Steven M. Kawut, Joseph Loscalzo, Donald McDonald, Ivan F. McMurtry, John Newman, Mark Nicolls, Marlene Rabinovitch, Judy Shizuru, Masahiko Oka, Peter Polgar, David Rodman, Paul Schumacker, Kurt Stenmark, Rubin Tuder, Norbert Voelkel, Eugene Sullivan, Richard M Weinshilboum, Mervin C. Yoder, Yingming Zhao, Dorothy Gail, Timothy M. Moore

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals to enhance and accelerate research that will result in improved understanding of the lung vasculature, translational research needs, and ultimately the care of patients with pulmonary vascular diseases. Multidisciplinary experts with diverse experience in laboratory, translational, and clinical studies identified seven priority areas and discussed limitations in our current knowledge, technologies, and approaches. The focus for future research efforts include the following: (1) better characterizing vascular genotype-phenotype relationships and incorporating systems biology approaches when appropriate; (2) advancing our understanding of pulmonary vascular metabolic regulatory signaling in health and disease; (3) expanding our knowledge of the biologic relationships between the lung circulation and circulating elements, systemic vascular function, and right heart function and disease; (4) improving translational research for identifying disease-modifying therapies for the pulmonary hypertensive diseases; (5) establishing an appropriate and effective platform for advancing translational findings into clinical studies testing; and (6) developing the specific technologies and tools that will be enabling for these goals, such as question-guided imaging techniques and lung vascular investigator training programs. Recommendations from this workshop will be used within the Lung Vascular Biology and Disease Extramural Research Programfor planning and strategic implementation purposes.

Original languageEnglish (US)
Pages (from-to)1554-1562
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume182
Issue number12
DOIs
StatePublished - Dec 15 2010

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Blood Vessels
Education
Lung
Lung Diseases
Research
Translational Medical Research
Vascular Diseases
Technology
Systems Biology
Rare Diseases
Heart Diseases
Patient Care
Genotype
Research Personnel
Phenotype
Health

Keywords

  • Genomics
  • Metabolism
  • Phenotyping
  • Pulmonary hypertension
  • Right ventricle

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Erzurum, S., Rounds, S. I., Stevens, T., Aldred, M., Aliotta, J., Archer, S. L., ... Moore, T. M. (2010). Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report. American Journal of Respiratory and Critical Care Medicine, 182(12), 1554-1562. https://doi.org/10.1164/rccm.201006-0869WS

Strategic plan for lung vascular research : An NHLBI-ORDR Workshop Report. / Erzurum, Serpil; Rounds, Sharon I.; Stevens, Troy; Aldred, Micheala; Aliotta, Jason; Archer, Stephen L.; Asosingh, Kewal; Balaban, Robert; Bauer, Natalie; Bhattacharya, Jahar; Bogaard, Harm; Choudhary, Gaurav; Dorn, Gerald W.; Dweik, Raed; Fagan, Karen; Fallon, Michael; Finkel, Toren; Geraci, Mark; Gladwin, Mark T.; Hassoun, Paul M.; Humbert, Marc; Kaminski, Naftali; Kawut, Steven M.; Loscalzo, Joseph; McDonald, Donald; McMurtry, Ivan F.; Newman, John; Nicolls, Mark; Rabinovitch, Marlene; Shizuru, Judy; Oka, Masahiko; Polgar, Peter; Rodman, David; Schumacker, Paul; Stenmark, Kurt; Tuder, Rubin; Voelkel, Norbert; Sullivan, Eugene; Weinshilboum, Richard M; Yoder, Mervin C.; Zhao, Yingming; Gail, Dorothy; Moore, Timothy M.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 182, No. 12, 15.12.2010, p. 1554-1562.

Research output: Contribution to journalArticle

Erzurum, S, Rounds, SI, Stevens, T, Aldred, M, Aliotta, J, Archer, SL, Asosingh, K, Balaban, R, Bauer, N, Bhattacharya, J, Bogaard, H, Choudhary, G, Dorn, GW, Dweik, R, Fagan, K, Fallon, M, Finkel, T, Geraci, M, Gladwin, MT, Hassoun, PM, Humbert, M, Kaminski, N, Kawut, SM, Loscalzo, J, McDonald, D, McMurtry, IF, Newman, J, Nicolls, M, Rabinovitch, M, Shizuru, J, Oka, M, Polgar, P, Rodman, D, Schumacker, P, Stenmark, K, Tuder, R, Voelkel, N, Sullivan, E, Weinshilboum, RM, Yoder, MC, Zhao, Y, Gail, D & Moore, TM 2010, 'Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report', American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1554-1562. https://doi.org/10.1164/rccm.201006-0869WS
Erzurum, Serpil ; Rounds, Sharon I. ; Stevens, Troy ; Aldred, Micheala ; Aliotta, Jason ; Archer, Stephen L. ; Asosingh, Kewal ; Balaban, Robert ; Bauer, Natalie ; Bhattacharya, Jahar ; Bogaard, Harm ; Choudhary, Gaurav ; Dorn, Gerald W. ; Dweik, Raed ; Fagan, Karen ; Fallon, Michael ; Finkel, Toren ; Geraci, Mark ; Gladwin, Mark T. ; Hassoun, Paul M. ; Humbert, Marc ; Kaminski, Naftali ; Kawut, Steven M. ; Loscalzo, Joseph ; McDonald, Donald ; McMurtry, Ivan F. ; Newman, John ; Nicolls, Mark ; Rabinovitch, Marlene ; Shizuru, Judy ; Oka, Masahiko ; Polgar, Peter ; Rodman, David ; Schumacker, Paul ; Stenmark, Kurt ; Tuder, Rubin ; Voelkel, Norbert ; Sullivan, Eugene ; Weinshilboum, Richard M ; Yoder, Mervin C. ; Zhao, Yingming ; Gail, Dorothy ; Moore, Timothy M. / Strategic plan for lung vascular research : An NHLBI-ORDR Workshop Report. In: American Journal of Respiratory and Critical Care Medicine. 2010 ; Vol. 182, No. 12. pp. 1554-1562.
@article{b11e9024514a4d21b4340f46e435058b,
title = "Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report",
abstract = "The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals to enhance and accelerate research that will result in improved understanding of the lung vasculature, translational research needs, and ultimately the care of patients with pulmonary vascular diseases. Multidisciplinary experts with diverse experience in laboratory, translational, and clinical studies identified seven priority areas and discussed limitations in our current knowledge, technologies, and approaches. The focus for future research efforts include the following: (1) better characterizing vascular genotype-phenotype relationships and incorporating systems biology approaches when appropriate; (2) advancing our understanding of pulmonary vascular metabolic regulatory signaling in health and disease; (3) expanding our knowledge of the biologic relationships between the lung circulation and circulating elements, systemic vascular function, and right heart function and disease; (4) improving translational research for identifying disease-modifying therapies for the pulmonary hypertensive diseases; (5) establishing an appropriate and effective platform for advancing translational findings into clinical studies testing; and (6) developing the specific technologies and tools that will be enabling for these goals, such as question-guided imaging techniques and lung vascular investigator training programs. Recommendations from this workshop will be used within the Lung Vascular Biology and Disease Extramural Research Programfor planning and strategic implementation purposes.",
keywords = "Genomics, Metabolism, Phenotyping, Pulmonary hypertension, Right ventricle",
author = "Serpil Erzurum and Rounds, {Sharon I.} and Troy Stevens and Micheala Aldred and Jason Aliotta and Archer, {Stephen L.} and Kewal Asosingh and Robert Balaban and Natalie Bauer and Jahar Bhattacharya and Harm Bogaard and Gaurav Choudhary and Dorn, {Gerald W.} and Raed Dweik and Karen Fagan and Michael Fallon and Toren Finkel and Mark Geraci and Gladwin, {Mark T.} and Hassoun, {Paul M.} and Marc Humbert and Naftali Kaminski and Kawut, {Steven M.} and Joseph Loscalzo and Donald McDonald and McMurtry, {Ivan F.} and John Newman and Mark Nicolls and Marlene Rabinovitch and Judy Shizuru and Masahiko Oka and Peter Polgar and David Rodman and Paul Schumacker and Kurt Stenmark and Rubin Tuder and Norbert Voelkel and Eugene Sullivan and Weinshilboum, {Richard M} and Yoder, {Mervin C.} and Yingming Zhao and Dorothy Gail and Moore, {Timothy M.}",
year = "2010",
month = "12",
day = "15",
doi = "10.1164/rccm.201006-0869WS",
language = "English (US)",
volume = "182",
pages = "1554--1562",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "12",

}

TY - JOUR

T1 - Strategic plan for lung vascular research

T2 - An NHLBI-ORDR Workshop Report

AU - Erzurum, Serpil

AU - Rounds, Sharon I.

AU - Stevens, Troy

AU - Aldred, Micheala

AU - Aliotta, Jason

AU - Archer, Stephen L.

AU - Asosingh, Kewal

AU - Balaban, Robert

AU - Bauer, Natalie

AU - Bhattacharya, Jahar

AU - Bogaard, Harm

AU - Choudhary, Gaurav

AU - Dorn, Gerald W.

AU - Dweik, Raed

AU - Fagan, Karen

AU - Fallon, Michael

AU - Finkel, Toren

AU - Geraci, Mark

AU - Gladwin, Mark T.

AU - Hassoun, Paul M.

AU - Humbert, Marc

AU - Kaminski, Naftali

AU - Kawut, Steven M.

AU - Loscalzo, Joseph

AU - McDonald, Donald

AU - McMurtry, Ivan F.

AU - Newman, John

AU - Nicolls, Mark

AU - Rabinovitch, Marlene

AU - Shizuru, Judy

AU - Oka, Masahiko

AU - Polgar, Peter

AU - Rodman, David

AU - Schumacker, Paul

AU - Stenmark, Kurt

AU - Tuder, Rubin

AU - Voelkel, Norbert

AU - Sullivan, Eugene

AU - Weinshilboum, Richard M

AU - Yoder, Mervin C.

AU - Zhao, Yingming

AU - Gail, Dorothy

AU - Moore, Timothy M.

PY - 2010/12/15

Y1 - 2010/12/15

N2 - The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals to enhance and accelerate research that will result in improved understanding of the lung vasculature, translational research needs, and ultimately the care of patients with pulmonary vascular diseases. Multidisciplinary experts with diverse experience in laboratory, translational, and clinical studies identified seven priority areas and discussed limitations in our current knowledge, technologies, and approaches. The focus for future research efforts include the following: (1) better characterizing vascular genotype-phenotype relationships and incorporating systems biology approaches when appropriate; (2) advancing our understanding of pulmonary vascular metabolic regulatory signaling in health and disease; (3) expanding our knowledge of the biologic relationships between the lung circulation and circulating elements, systemic vascular function, and right heart function and disease; (4) improving translational research for identifying disease-modifying therapies for the pulmonary hypertensive diseases; (5) establishing an appropriate and effective platform for advancing translational findings into clinical studies testing; and (6) developing the specific technologies and tools that will be enabling for these goals, such as question-guided imaging techniques and lung vascular investigator training programs. Recommendations from this workshop will be used within the Lung Vascular Biology and Disease Extramural Research Programfor planning and strategic implementation purposes.

AB - The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals to enhance and accelerate research that will result in improved understanding of the lung vasculature, translational research needs, and ultimately the care of patients with pulmonary vascular diseases. Multidisciplinary experts with diverse experience in laboratory, translational, and clinical studies identified seven priority areas and discussed limitations in our current knowledge, technologies, and approaches. The focus for future research efforts include the following: (1) better characterizing vascular genotype-phenotype relationships and incorporating systems biology approaches when appropriate; (2) advancing our understanding of pulmonary vascular metabolic regulatory signaling in health and disease; (3) expanding our knowledge of the biologic relationships between the lung circulation and circulating elements, systemic vascular function, and right heart function and disease; (4) improving translational research for identifying disease-modifying therapies for the pulmonary hypertensive diseases; (5) establishing an appropriate and effective platform for advancing translational findings into clinical studies testing; and (6) developing the specific technologies and tools that will be enabling for these goals, such as question-guided imaging techniques and lung vascular investigator training programs. Recommendations from this workshop will be used within the Lung Vascular Biology and Disease Extramural Research Programfor planning and strategic implementation purposes.

KW - Genomics

KW - Metabolism

KW - Phenotyping

KW - Pulmonary hypertension

KW - Right ventricle

UR - http://www.scopus.com/inward/record.url?scp=78650186826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650186826&partnerID=8YFLogxK

U2 - 10.1164/rccm.201006-0869WS

DO - 10.1164/rccm.201006-0869WS

M3 - Article

C2 - 20833821

AN - SCOPUS:78650186826

VL - 182

SP - 1554

EP - 1562

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 12

ER -